Enveric Biosciences Ownership 2024 | Who Owns Enveric Biosciences Now?

Overview RevenueFinancials Chart

Institutional Ownership

12.64%

Insider Ownership

2.42%

Retail Ownership

84.94%

Institutional Holders

17.00

Enveric Biosciences Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORSHARES INVESTMENTS LLC	7.92%	0.03%	317,047	78,214	32.75%	189,911	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	1.12%	-	44,659	31,541	240.44%	27,688	Jun 30, 2024
UBS GROUP AG	1.09%	-	43,560	38,577	774.17%	27,268	Jun 30, 2024
BLACKROCK INC.	0.74%	-	29,578	-	-	18,522	Jun 30, 2024
VANGUARD GROUP INC	0.45%	-	18,198	-	-	11,396	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	0.38%	0.00%	15,240	15,240	100.00%	9,543	Jun 30, 2024
VIRTU FINANCIAL LLC	0.34%	0.00%	13,792	-20,043	-59.24%	9,000	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.29%	0.00%	11,455	-822	-6.70%	7,171	Jun 30, 2024
HRT FINANCIAL LP	0.27%	-	10,972	-52,054	-82.59%	6,000	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.02%	-	615	465	310.00%	385	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.01%	-	273	-	-	169,000	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	164	64	64.00%	103	Jun 30, 2024
FMR LLC	0.00%	-	120	120	100.00%	74	Jun 30, 2024
NATIONAL BANK OF CANADA /FI/	0.00%	-	70	-	-	41	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	16	-21	-56.76%	10	Jun 30, 2024
ORG PARTNERS LLC	0.00%	-	10	10	100.00%	5,000	Jun 30, 2024
MATHER GROUP, LLC.	0.00%	-	8	8	100.00%	8	Jun 30, 2024
MORGAN STANLEY	-	-	-	-1	-100.00%	-	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-15,397	-100.00%	-	Jun 30, 2024

Enveric Biosciences's largest institutional shareholder is ADVISORSHARES INVESTMENTS LLC, holding 7.92% of the company's total share outstanding, currently valued at $189.91K. The top 10 institutional shareholders own together 12.62% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORSHARES INVESTMENTS LLC	7.92%	0.03%	317,047	78,214	32.75%	189,911	Jun 30, 2024
VIRTU FINANCIAL LLC	0.34%	0.00%	13,792	-20,043	-59.24%	9,000	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.29%	0.00%	11,455	-822	-6.70%	7,171	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	0.38%	0.00%	15,240	15,240	100.00%	9,543	Jun 30, 2024
HRT FINANCIAL LP	0.27%	-	10,972	-52,054	-82.59%	6,000	Jun 30, 2024
UBS GROUP AG	1.09%	-	43,560	38,577	774.17%	27,268	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	1.12%	-	44,659	31,541	240.44%	27,688	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.02%	-	615	465	310.00%	385	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.01%	-	273	-	-	169,000	Jun 30, 2024
ORG PARTNERS LLC	0.00%	-	10	10	100.00%	5,000	Jun 30, 2024
BLACKROCK INC.	0.74%	-	29,578	-	-	18,522	Jun 30, 2024
VANGUARD GROUP INC	0.45%	-	18,198	-	-	11,396	Jun 30, 2024
MATHER GROUP, LLC.	0.00%	-	8	8	100.00%	8	Jun 30, 2024
NATIONAL BANK OF CANADA /FI/	0.00%	-	70	-	-	41	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	164	64	64.00%	103	Jun 30, 2024
FMR LLC	0.00%	-	120	120	100.00%	74	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	16	-21	-56.76%	10	Jun 30, 2024
MORGAN STANLEY	-	-	-	-1	-100.00%	-	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-15,397	-100.00%	-	Jun 30, 2024

The largest Enveric Biosciences shareholder by % of total assets is ADVISORSHARES INVESTMENTS LLC. The company owns 317.05K shares of Enveric Biosciences (ENVB), representing 0.03% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ADVISORSHARES INVESTMENTS LLC	7.92%	0.03%	317,047	78,214	32.75%	189,911	Jun 30, 2024
UBS GROUP AG	1.09%	-	43,560	38,577	774.17%	27,268	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	1.12%	-	44,659	31,541	240.44%	27,688	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	0.38%	0.00%	15,240	15,240	100.00%	9,543	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.02%	-	615	465	310.00%	385	Jun 30, 2024
FMR LLC	0.00%	-	120	120	100.00%	74	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	164	64	64.00%	103	Jun 30, 2024
ORG PARTNERS LLC	0.00%	-	10	10	100.00%	5,000	Jun 30, 2024
MATHER GROUP, LLC.	0.00%	-	8	8	100.00%	8	Jun 30, 2024
NATIONAL BANK OF CANADA /FI/	0.00%	-	70	-	-	41	Jun 30, 2024
VANGUARD GROUP INC	0.45%	-	18,198	-	-	11,396	Jun 30, 2024
BLACKROCK INC.	0.74%	-	29,578	-	-	18,522	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.01%	-	273	-	-	169,000	Jun 30, 2024
MORGAN STANLEY	-	-	-	-1	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	16	-21	-56.76%	10	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.29%	0.00%	11,455	-822	-6.70%	7,171	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-15,397	-100.00%	-	Jun 30, 2024
VIRTU FINANCIAL LLC	0.34%	0.00%	13,792	-20,043	-59.24%	9,000	Jun 30, 2024
HRT FINANCIAL LP	0.27%	-	10,972	-52,054	-82.59%	6,000	Jun 30, 2024

As of Jun 30 2024, Enveric Biosciences's largest institutional buyer is ADVISORSHARES INVESTMENTS LLC. The company purchased 78.21K stocks of ENVB, valued at $189.91K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HRT FINANCIAL LP	0.27%	-	10,972	-52,054	-82.59%	6,000	Jun 30, 2024
VIRTU FINANCIAL LLC	0.34%	0.00%	13,792	-20,043	-59.24%	9,000	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	-	-	-	-15,397	-100.00%	-	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.29%	0.00%	11,455	-822	-6.70%	7,171	Jun 30, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	16	-21	-56.76%	10	Jun 30, 2024
MORGAN STANLEY	-	-	-	-1	-100.00%	-	Jun 30, 2024
GROUP ONE TRADING, L.P.	0.01%	-	273	-	-	169,000	Jun 30, 2024
BLACKROCK INC.	0.74%	-	29,578	-	-	18,522	Jun 30, 2024
VANGUARD GROUP INC	0.45%	-	18,198	-	-	11,396	Jun 30, 2024
NATIONAL BANK OF CANADA /FI/	0.00%	-	70	-	-	41	Jun 30, 2024
MATHER GROUP, LLC.	0.00%	-	8	8	100.00%	8	Jun 30, 2024
ORG PARTNERS LLC	0.00%	-	10	10	100.00%	5,000	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.00%	-	164	64	64.00%	103	Jun 30, 2024
FMR LLC	0.00%	-	120	120	100.00%	74	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.02%	-	615	465	310.00%	385	Jun 30, 2024
TWO SIGMA SECURITIES, LLC	0.38%	0.00%	15,240	15,240	100.00%	9,543	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	1.12%	-	44,659	31,541	240.44%	27,688	Jun 30, 2024
UBS GROUP AG	1.09%	-	43,560	38,577	774.17%	27,268	Jun 30, 2024
ADVISORSHARES INVESTMENTS LLC	7.92%	0.03%	317,047	78,214	32.75%	189,911	Jun 30, 2024

As of Jun 30 2024, Enveric Biosciences's biggest institutional seller is HRT FINANCIAL LP. The company sold -52.05K shares of ENVB, valued at $6.00K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TWO SIGMA SECURITIES, LLC	0.38%	0.00%	15,240	15,240	100.00%	9,543	Jun 30, 2024
FMR LLC	0.00%	-	120	120	100.00%	74	Jun 30, 2024
MATHER GROUP, LLC.	0.00%	-	8	8	100.00%	8	Jun 30, 2024

Enveric Biosciences's largest new institutional shareholder by number of shares is TWO SIGMA SECURITIES, LLC, purchased 15.24K shares, valued at $9.54K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TWO SIGMA INVESTMENTS, LP	-	-	-	-15,397	-100.00%	-	Jun 30, 2024
MORGAN STANLEY	-	-	-	-1	-100.00%	-	Jun 30, 2024

Enveric Biosciences's largest sold out institutional shareholder by shares sold is TWO SIGMA INVESTMENTS, LP, sold -15.40K shares, valued at -, as of undefined.

Enveric Biosciences Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
AdvisorShares Trust	0.31%	1,252,390	-	-	Mar 28, 2024
AdvisorShares Trust	0.06%	238,833	97,000	68.39%	Mar 28, 2024
VANGUARD INDEX FUNDS	0.00%	755,039	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	166,226	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	12,859	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	18,198	-18,198	-50.00%	Mar 31, 2024
ADVANCED SERIES TRUST	0.00%	107,500	-	-	Mar 28, 2024
EQ ADVISORS TRUST	0.00%	4,301	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	44,243	-	-	Mar 31, 2024
Blackstone Alternative Investment Funds	0.00%	11	-	-	Mar 31, 2023

Enveric Biosciences's largest mutual fund holder by % of total assets is "AdvisorShares Trust", owning 1.25M shares, compromising 0.31% of its total assets.

Enveric Biosciences Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	17	-
31 Mar, 24	17	21.43%
31 Dec, 23	14	-
30 Sep, 23	14	-
30 Jun, 23	14	16.67%
31 Mar, 23	12	20.00%
31 Dec, 22	10	25.00%
30 Sep, 22	8	700.00%
30 Jun, 22	1	-

As of 30 Jun 24, 17 institutions are holding Enveric Biosciences's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	505,777	3.59%
31 Mar, 24	488,227	-0.17%
31 Dec, 23	489,048	119.43%
30 Sep, 23	222,867	19.01%
30 Jun, 23	187,268	-17.82%
31 Mar, 23	227,883	31.78%
31 Dec, 22	172,925	17.24%
30 Sep, 22	147,491	-88.22%
30 Jun, 22	1,252,390	-

Enveric Biosciences (ENVB) has 505.78K shares outstanding as of 30 Jun 24, up 3.59% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	12.64%	2.47%
31 Mar, 24	22.61%	4.43%
31 Dec, 23	22.59%	20.20%
30 Sep, 23	10.57%	13.02%
30 Jun, 23	9.01%	7.49%
31 Mar, 23	10.96%	7.67%
31 Dec, 22	11.96%	17.56%
30 Sep, 22	8.25%	146.06%
30 Jun, 22	2.38%	-

As of 30 Jun 24, Enveric Biosciences is held by 12.64% institutional shareholders, representing a 2.47% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	9	12.50%
31 Mar, 24	8	100.00%
31 Dec, 23	4	-50.00%
30 Sep, 23	8	-
30 Jun, 23	8	33.33%
31 Mar, 23	6	-
31 Dec, 22	6	-14.29%
30 Sep, 22	7	600.00%
30 Jun, 22	1	-

9 institutional shareholders have increased their position in ENVB stock as of 30 Jun 24 compared to 8 in the previous quarter (a 12.50% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	4	300.00%
31 Mar, 24	1	-75.00%
31 Dec, 23	4	300.00%
30 Sep, 23	1	-66.67%
30 Jun, 23	3	200.00%
31 Mar, 23	1	-50.00%
31 Dec, 22	2	100.00%
30 Sep, 22	1	-
30 Jun, 22	-	-

4 institutional shareholders have reduced their position in ENVB stock as of 30 Jun 24 compared to 1 in the previous quarter (a 300.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	17	-	505,777	3.59%	12.64%	2.47%	9	12.50%	4	300.00%
31 Mar, 24	17	21.43%	488,227	-0.17%	22.61%	4.43%	8	100.00%	1	-75.00%
31 Dec, 23	14	-	489,048	119.43%	22.59%	20.20%	4	-50.00%	4	300.00%
30 Sep, 23	14	-	222,867	19.01%	10.57%	13.02%	8	-	1	-66.67%
30 Jun, 23	14	16.67%	187,268	-17.82%	9.01%	7.49%	8	33.33%	3	200.00%
31 Mar, 23	12	20.00%	227,883	31.78%	10.96%	7.67%	6	-	1	-50.00%
31 Dec, 22	10	25.00%	172,925	17.24%	11.96%	17.56%	6	-14.29%	2	100.00%
30 Sep, 22	8	700.00%	147,491	-88.22%	8.25%	146.06%	7	600.00%	1	-
30 Jun, 22	1	-	1,252,390	-	2.38%	-	1	-	-	-

Enveric Biosciences Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Sep 19, 2023	PASQUALONE FRANK	director	-	P-Purchase	Buy	1,000	$2.14	$2.14K	1,000

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Sep 19, 2023	PASQUALONE FRANK	director	-	P-Purchase	Buy	1,000	$2.14	$2.14K	1,000

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 03, 2024	DeWitt Sheila		-		Buy	-	-	-	-
Feb 26, 2024	Tucker Joseph Edward	director, officer	CHIEF EXECUTIVE OFFICER	A-Award	Buy	100,000	-	-	174,196
Feb 26, 2024	Facchini Peter J.	officer	CHIEF INNOVATION OFFICER	A-Award	Buy	50,000	-	-	90,856
Feb 26, 2024	Coveney Kevin Michael	officer	CHIEF FINANCIAL OFFICER	A-Award	Buy	60,000	-	-	86,500
Sep 19, 2023	PASQUALONE FRANK	director	-	P-Purchase	Buy	1,000	$2.14	$2.14K	1,000
Mar 14, 2023	Coveney Kevin Michael	officer	Chief Financial Officer	A-Award	Buy	26,500	-	-	26,500
Mar 14, 2023	Coveney Kevin Michael	officer	-		Buy	-	-	-	-
Jan 27, 2023	Facchini Peter J.	officer	Chief Innovation Officer	A-Award	Buy	17,000	-	-	40,865
Jan 27, 2023	Hagel Jillian Marie	officer	Vice President of Innovation	A-Award	Buy	12,000	-	-	35,802
Jan 27, 2023	Kanubaddi Avani	officer	President and COO	A-Award	Buy	10,000	-	-	48,346
Jan 27, 2023	Tucker Joseph Edward	officer	Chief Executive Officer	A-Award	Buy	44,000	-	-	74,196
Jan 25, 2023	Hagel Jillian Marie	officer	Chief Technology Officer	A-Award	Buy	10,500	-	-	23,802
Jan 25, 2023	Hagel Jillian Marie	officer	Chief Technology Officer	A-Award	Buy	1,021	-	-	13,302
Jan 25, 2023	Facchini Peter J.	officer	Chief Scientific Officer	A-Award	Buy	10,500	-	-	23,856
Jan 25, 2023	Facchini Peter J.	officer	Chief Scientific Officer	A-Award	Buy	1,021	-	-	13,356
Jan 25, 2023	Tucker Joseph Edward	officer	Chief Executive Officer	A-Award	Buy	15,000	-	-	30,196
Jan 25, 2023	Tucker Joseph Edward	officer	Chief Executive Officer	A-Award	Buy	1,374	-	-	15,196
Sep 23, 2022	Dickey Robert IV	officer	-		Buy	-	-	-	-
Jul 22, 2022	PASQUALONE FRANK	director			Buy	-	-	-	-
Jul 05, 2022	O'NEIL BEVIN	director			Buy	-	-	-	-

The last insider buy of ENVB was made by PASQUALONE FRANK on Sep 19 2023, buying 1,000 shares at $2.14 per share (worth $2.14K).

Enveric Biosciences Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	5	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	2	-	-
Q4 2021	6	-	-
Q3 2021	21	-	-
Q2 2021	-	-	-
Q1 2021	8	-	-
Q4 2020	-	1	-
Q1 2019	1	-	-
Q4 2018	1	38	2.63%
Q3 2018	14	4	350.00%
Q2 2018	1	1	100.00%
Q1 2018	14	8	175.00%
Q4 2017	12	3	400.00%
Q3 2017	4	1	400.00%
Q2 2017	41	6	683.33%
Q1 2017	23	1	2300.00%
Q4 2016	17	1	1700.00%
Q3 2016	17	-	-

5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Enveric Biosciences's insiders, as of Q1 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2023	-	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	-	-	-
Q3 2021	-	-	-
Q2 2021	-	-	-
Q1 2021	-	-	-
Q4 2020	-	-	-
Q1 2019	-	-	-
Q4 2018	-	36	-
Q3 2018	-	1	-
Q2 2018	1	1	100.00%
Q1 2018	-	-	-
Q4 2017	8	-	-
Q3 2017	2	-	-
Q2 2017	-	-	-
Q1 2017	5	-	-
Q4 2016	8	-	-
Q3 2016	16	-	-

As of Q1 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Enveric Biosciences's stocks.

Enveric Biosciences Peer Ownership

Ticker	Company
CWBR	CohBar, Inc.
AVRO	AVROBIO, Inc.
EFTR	eFFECTOR Therapeutics, Inc.
OCEA	Ocean Biomedical, Inc.
HEPA	Hepion Pharmaceuticals, Inc.
ZURA	Zura Bio Limited
ELEV	Elevation Oncology, Inc.

ENVB Ownership FAQ

Who Owns Enveric Biosciences?

Enveric Biosciences is owned by institutional shareholders (12.64%), insiders (2.42%), and public (84.94%). The largest institutional shareholder of Enveric Biosciences is ADVISORSHARES INVESTMENTS LLC (7.92% of total shares) and the top mutual fund owner is AdvisorShares Trust (0.31% of total shares).

Who are the major institutional shareholders of Enveric Biosciences?

Enveric Biosciences's major institutional shareholders are ADVISORSHARES INVESTMENTS LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS GROUP AG, BLACKROCK INC., and VANGUARD GROUP INC. The top five shareholders own together 11.32% of the company's share outstanding.

How many Enveric Biosciences shareholders are there?

As of Jun 2024, there are 17 institutional shareholders of Enveric Biosciences.

What percentage of Enveric Biosciences is owned by ADVISORSHARES INVESTMENTS LLC?

ADVISORSHARES INVESTMENTS LLC owns 317.05K shares of Enveric Biosciences, representing 7.92% of the company's total shares outstanding, valued at $189.91K (as of Jun 2024).

What percentage of Enveric Biosciences is owned by GEODE CAPITAL MANAGEMENT, LLC?

As of Jun 2024, GEODE CAPITAL MANAGEMENT, LLC holds 44.66K shares of Enveric Biosciences (ENVB), compromising 1.12% of the company, valued at $27.69K.

What percentage of Enveric Biosciences is owned by UBS GROUP AG?

UBS GROUP AG is the third largest holder of Enveric Biosciences. The company owns 43.56K of the company's shares outstanding (worth $27.27K).